We found that Tnfr2 KD or the use of anti-TNFR2 antibodies could inhibit cancer cell proliferation directly, and induced the apoptosis of tumor cells in pancreatic cancer. The gene discussed is TNFRSF1B; the disease is pancreatic neoplasm.